1. Targeting the proliferative and chemoresistant compartment in chronic lymphocytic leukemia by inhibiting survivin protein
   N Purroy et al, 2014, Leukemia CrossRef
2. Resveratrol alleviates the cytotoxicity induced by the radiocontrast agent, ioxitalamate, by reducing the production of reactive oxygen species in HK-2 human renal proximal tubule epithelial cells in vitro
   YEN TA HUANG et al, 2016, International Journal of Molecular Medicine CrossRef
3. Inhibitor of apoptosis proteins as therapeutic targets in bladder cancer
   Philipp Wolf, 2023, Frontiers in Oncology CrossRef
4. Exposure of Bladder Cancer Cells to Blue Light (λ = 453 nm) in the Presence of Riboflavin Synergistically Enhances the Cytotoxic Efficiency of Gemcitabine
   Sofia Sturm et al, 2024, International Journal of Molecular Sciences CrossRef
5. Therapeutic potential of thalidomide for gemcitabine-resistant bladder cancer
   YEN TA HUANG et al, 2015, International Journal of Oncology CrossRef
6. Chemoresistance in pancreatic cancer: Emerging concepts
   Manu Gnanamony et al, 2017, Oncology Letters CrossRef
7. Multifaceted Mechanisms of Cisplatin Resistance in Long-Term Treated Urothelial Carcinoma Cell Lines
   Margaretha Skowron et al, 2018, International Journal of Molecular Sciences CrossRef
8. Examination of survivin expression in 50 chordoma specimens—A histological and in vitro study
   Elke V. Froehlich et al, 2015, Journal of Orthopaedic Research CrossRef
9. Advances in therapeutic agents targeting quiescent cancer cells
   Wan Najbah Nik Nabil et al, 2022, Acta Materia Medica CrossRef
10. Autophagy and urothelial carcinoma of the bladder: A review
    Thenappan Chandrasekar et al, 2016, Investigative and Clinical Urology CrossRef